Page last updated: 2024-12-11

bacopaside ii

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

bacopaside II: isolated from Bacopa monniera Wettst; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
BacopagenusA plant genus of the family Plantaginaceae. Members contain bacopaside, bacopasaponins and other dammarane type jujubogenins.[MeSH]PlantaginaceaeA plant family of order Lamiales. The Plantago genus is best known. Lesser known members include Hippuris, Littorella and Callitriche.[MeSH]

Cross-References

ID SourceID
PubMed CID9876264
MeSH IDM0408599

Synonyms (15)

Synonym
bacopaside ii
3-o-alpha-l-arabinofuranosyl-(1-2)-(beta-d-glucopyranosyl (1-3))-beta-d-glucopyranosyl pseudo-jujubogenin
382146-66-9
unii-zo6l404y9t
bacopaside ii (constituent of bacopa) [dsc]
ZO6L404Y9T ,
bacopaside ii, (-)-
HY-N6016
CS-0032179
Q27295806
bacopaside ii(p)
XB177549
AS-82707
DTXSID201347350
AKOS040760287

Research Excerpts

Overview

Bacopaside II is a major component of Bacopa monnieri. We studied its inhibitory effects and binding affinity towards the MARK4.

ExcerptReferenceRelevance
"Bacopaside II is a major component of Bacopa monnieri; thus, we studied its inhibitory effects and binding affinity towards the MARK4."( Investigating MARK4 inhibitory potential of Bacopaside II: Targeting Alzheimer's disease.
Alam, A; Anwar, S; Azhar, MK; Fatima, H; Hasan, GM; Hassan, MI; Islam, A; Kaur, P; Mohammad, T, 2023
)
1.89
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (25.00)29.6817
2010's8 (66.67)24.3611
2020's1 (8.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.46

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.46 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.72 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.46)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (8.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]